ERS Publications Podcasts

As part of the September issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Associate Editor Marcus Mall about neutrophil-derived biomarkers in bronchiectasis, as discussed in his review article in this issue of the ERJ: https://doi.org/10.1183/13993003.00081-2025 Correction: At 5 min 54 s in this podcast, in response to a question from D. Sin regarding the dosing of azithromycin, M. Mall mistakenly replied that “For the immunomodulatory effects, it would be a standard long-term therapy with a three times per day regimen.” He meant to say “three times per week”. We apologise for this error. Cite this podcast as: ERJ Podcast September 2025: Neutrophil-derived biomarkers in bronchiectasis. Eur Respir J 2025; 55: 25E6603. [https://doi.org/10.1183/13993003.E6603-2025]

“We really need to celebrate the exciting times in asthma but also focus on the advocacy for improving outcomes in research and in clinical practice” Leading asthma experts David Jackson, Vanessa McDonald and Ian Pavord meet with Monograph Editorial Board member Dorina Esendagli to discuss their 500-page authoritative guide to the latest developments in the field. They discuss pathophysiology, treatable traits, biomarkers, comorbidities, the importance of the multidisciplinary team, and the personal experiences that gave them a genuine passion for helping asthma patients.

As part of the January issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Dr Peter Gibson about distinct trajectories of treatment response to mepolizumab toward remission in patients with severe eosinophilic asthma.

As part of the May issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews Associate Editor Marius Hoeper about the efficacy and safety of the activin signalling inhibitor sotatercept in a pooled analysis of PULSAR and STELLAR studies.

As part of the March issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Associate Editor Yet Khor about the generalisability of pharmaceutical randomised controlled trial eligibility criteria for progressive pulmonary fibrosis.

Leaders in the transplantation field and well-regarded ERS Officers, Michael Perch and Federica Meloni, join Dorina Esendagli in a podcast focusing on the latest Monograph: Lung Transplantation. Covering the formidable topics of immunosuppressive treatment and post-transplant care, it is clear that both the podcast and book are hugely relevant to the transplant specialist. However, Michael and Federica explain that the book is also aimed at specialists in other areas of pneumology, as well as general physicians from beyond the respiratory field. Broadening understanding about this challenging area is essential if we are to improve prognosis and widen donor availability.

As part of the November issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews editorial board member Sanjay Chotirmall about articles published from in the current issue.